Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 1567120, 10 pages
https://doi.org/10.1155/2017/1567120
Research Article

IL-34 Upregulated Th17 Production through Increased IL-6 Expression by Rheumatoid Fibroblast-Like Synoviocytes

1Department of Immunology, College of Basic Medical Science, Dalian Medical University, Liaoning, China
2Department of Rheumatology and Immunology, The Third Affiliated Hospital of Hebei Medical University, Hebei, China
3Department of Microecology, College of Basic Medical Science, Dalian Medical University, Liaoning, China
4Department of Rheumatology and Immunology, The Second Affiliated Hospital of Dalian Medical University, Liaoning, China

Correspondence should be addressed to Fang Li; moc.liamtoh@61gnafil and Xia Li; moc.361@614aixil

Received 30 September 2016; Revised 28 December 2016; Accepted 20 April 2017; Published 4 June 2017

Academic Editor: Sandra Helena Penha Oliveira

Copyright © 2017 Bing Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England Journal of Medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Publisher · View at Google Scholar
  2. J. D. Turner and A. Filer, “The role of the synovial fibroblast in rheumatoidarthritis pathogenesis,” Current Opinion in Rheumatology, vol. 27, no. 2, pp. 175–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. I. B. McInnes and G. Schett, “Cytokines in the pathogenesis of rheumatoid arthritis,” Nature Reviews. Immunology, vol. 7, no. 6, pp. 429–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Lin, E. Lee, K. Hestir et al., “Discovery of a cytokine and its receptor by functional screening of the extracellular proteome,” Science, vol. 320, no. 5877, pp. 807–811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Nakamichi, N. Udagawa, and N. Takahashi, “IL-34 and CSF-1: similarities and differences,” Journal of Bone and Mineral Metabolism, vol. 31, no. 5, pp. 486–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Wei, S. Nandi, V. Chitu et al., “Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells,” Journal of Leukocyte Biology, vol. 88, no. 3, pp. 495–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Wang, K. J. Szretter, W. Vermi et al., “IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia,” Nature Immunology, vol. 13, no. 8, pp. 753–760, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Felix, S. De Munck, K. Verstraete et al., “Structure and assembly mechanism of the signaling complex mediated by human CSF-1,” Structure, vol. 23, no. 9, pp. 1621–1631, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. E. L. Masteller and B. R. Wong, “Targeting IL-34 in chronic inflammation,” Drug Discovery Today, vol. 19, no. 8, pp. 1212–1216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. E. R. Stanley and V. Chitu, “CSF-1 receptor signaling in myeloid cells,” Cold Spring Harbor Perspectives in Biology, vol. 6, no. 6, article a021857, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Boström and P. Lundberg, “The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation,” PLoS One, vol. 8, no. 12, article e81665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang and M. Colonna, “Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells,” European Journal of Immunology, vol. 44, no. 6, pp. 1575–1581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Ciccia, R. Alessandro, V. Rodolico et al., “IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes,” Rheumatology (Oxford), vol. 52, no. 6, pp. 1009–1017, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Franzè, I. Marafini, V. De Simone et al., “Interleukin-34 induces cc-chemokine ligand 20 in gut epithelial cells,” Journal of Crohn’s and Colitis, vol. 10, no. 1, pp. 87–94, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Hwang, B. Choi, S. S. Kang et al., “Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis,” Arthritis Research & Therapy, vol. 14, no. 1, p. R14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Tian, H. Shen, L. Xia, and J. Lu, “Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production,” Journal of Interferon & Cytokine Research, vol. 33, no. 7, pp. 398–401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Chemel, B. Le Goff, R. Brion et al., “Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients,” Annals of the Rheumatic Diseases, vol. 71, no. 1, pp. 150–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Eda, H. Shimada, D. R. Beidler, and J. B. Monahan, “Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK-and p44/42 MAPK-NF-κB pathway but not P38 pathway in osteoblasts,” Rheumatology International, vol. 31, no. 11, pp. 1525–1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Clavel, A. Thiolat, and M. C. Boissier, “Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38,” Joint, Bone, Spine, vol. 80, no. 5, pp. 449–453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. Moon, Y. S. Hong, J. H. Ju, S. K. Kwok, S. H. Park, and J. K. Min, “Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis,” The Journal of Rheumatology, vol. 40, no. 11, pp. 1842–1849, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Chang, B. Y. Choi, J. Choi et al., “Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis,” Rheumatology International, vol. 35, no. 1, pp. 71–79, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Chen, K. Buki, J. Vääräniemi, G. Gu, and H. K. Väänänen, “The critical role of IL-34 in osteoclastogenesis,” PLoS One, vol. 6, no. 12, article e18689, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Mihara, M. Hashizume, H. Yoshida, M. Suzuki, and M. Shiina, “IL-6/IL-6 receptor system and its role in physiological and pathological conditions,” Clinical Science (London, England), vol. 122, no. 4, pp. 143–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Hashizume and M. Mihara, “The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis,” Arthritis, vol. 2011, Article ID 765624, p. 8, 2011. View at Publisher · View at Google Scholar
  25. T. B. Ferreira, J. Hygino, P. O. Barros et al., “Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis,” Immunology, vol. 143, no. 4, pp. 560–568, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Lin, Z. Zhou, R. Huo et al., “Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis,” Journal of Immunology, vol. 188, no. 11, pp. 5776–5784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Mouchemore and F. J. Pixley, “CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways,” Critical Reviews in Clinical Laboratory Sciences, vol. 49, no. 2, pp. 49–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Y. Zhou, Y. Li, W. Q. Jiang, and L. F. Zhou, “MAPK/JNK signalling: a potential autophagy regulation pathway,” Bioscience Reports, vol. 35, no. 3, article e00199, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. J. A. McCubrey, L. S. Steelman, W. H. Chappell et al., “Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance,” Biochimica et Biophysica Acta, vol. 1773, no. 8, pp. 1263–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Zarubin and J. Han, “Activation and signaling of the P38 MAP kinase pathway,” Cell Research, vol. 15, no. 1, pp. 11–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. S. Hayden and S. Ghosh, “Regulation of NF-κB by TNF family cytokines,” Seminars in Immunology, vol. 26, no. 3, pp. 253–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Lelli, A. Gervais, C. Colin et al., “The NADPH oxidase Nox2 regulates VEGFR1/CSF-1R-mediated microglial chemotaxis and promotes early postnatal infiltration of phagocytes in the subventricular zone of the mouse cerebral cortex,” Glia, vol. 61, no. 9, pp. 542–1555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. A. Elshabrawy, Z. Chen, M. V. Volin, S. Ravella, S. Virupannavar, and S. Shahrara, “The pathogenic role of angiogenesis in rheumatoid arthritis,” Angiogenesis, vol. 18, no. 4, pp. 433–448, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. E. T. Price, G. J. Welder, and I. Zineh, “Modulatory effect of fenofibrate on endothelial production of neutrophil chemokines IL-8 and ENA-78,” Cardiovascular Drugs and Therapy, vol. 26, no. 2, pp. 95–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Takamura, Y. Osuga, G. Izumi et al., “Interleukin-17A is present in neutrophils in endometrioma and stimulates the secretion of growth-regulated oncogene-α (Gro-α) from endometrioma stromal cells,” Fertility and Sterility, vol. 98, no. 5, pp. 1218–1224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. M. Lin, C. J. Hsu, Y. Y. Liao, M. C. Chou, and C. H. Tang, “The CCL2/CCR2 axis enhances vascular cell adhesion molecule-1 expression in human synovial fibroblasts,” PLoS One, vol. 7, no. 12, article e49999, 2012. View at Publisher · View at Google Scholar · View at Scopus